Restoring sensitivity to timolol after long-term drift in primary open-angle glaucoma
- PMID: 2406218
Restoring sensitivity to timolol after long-term drift in primary open-angle glaucoma
Abstract
In a prospective randomized single-masked study lasting 6 months, 39 eyes with primary open-angle glaucoma showing a long-term drift with 0.5% timolol were put on a "timolol holiday" lasting 30 or 60 days. Twenty-three of them were enrolled with dipivefrin 0.1% twice daily during the holiday. When timolol therapy was restored, the dipivefrin-treated group showed a more pronounced decrease of intraocular pressure (IOP) (8.2 +/- 1.5), whereas the IOP decrease in the nondipivefrin-treated group was lower (3.9 +/- 1.2) and of shorter duration (less than 60 days). Among the dipivefrin-treated group, the response to timolol was more prolonged in the eyes treated for 60 days: the IOP of these eyes was less than 23 mmHg throughout the follow-up.
Similar articles
-
Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans.Invest Ophthalmol Vis Sci. 1996 Mar;37(4):684-8. Invest Ophthalmol Vis Sci. 1996. PMID: 8595970 Clinical Trial.
-
A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.Ophthalmology. 1999 Mar;106(3):550-5. doi: 10.1016/S0161-6420(99)90115-X. Ophthalmology. 1999. PMID: 10080213 Clinical Trial.
-
Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.J Glaucoma. 1999 Feb;8(1):24-30. J Glaucoma. 1999. PMID: 10084271 Clinical Trial.
-
Initial treatment of glaucoma: surgery or medications.Surv Ophthalmol. 1993 Jan-Feb;37(4):293-305. doi: 10.1016/0039-6257(93)90013-w. Surv Ophthalmol. 1993. PMID: 8441955 Review.
-
Pilocarpine and dipivefrin.CLAO J. 1991 Apr;17(2):134. CLAO J. 1991. PMID: 2049823 Review. No abstract available.
Cited by
-
Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose-response phenomenon.Clin Ophthalmol. 2016 Mar 3;10:373-83. doi: 10.2147/OPTH.S98898. eCollection 2016. Clin Ophthalmol. 2016. PMID: 27041984 Free PMC article.
-
Long-term drift and timolol therapy: possible role for pulsed therapy.Int Ophthalmol. 1992 Sep;16(4-5):321-4. doi: 10.1007/BF00917984. Int Ophthalmol. 1992. PMID: 1428566
-
Topical timolol 0.5% gel-forming solution for erythema in rosacea: A quantitative, split-face, randomized, and rater-masked pilot clinical trial.J Am Acad Dermatol. 2021 Oct;85(4):1044-1046. doi: 10.1016/j.jaad.2021.01.098. Epub 2021 Feb 3. J Am Acad Dermatol. 2021. PMID: 33548303 Free PMC article. Clinical Trial. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources